The Case
A 22-year-old competitive lifter is found pacing in a hot gym, drenched in sweat, with a clenched jaw and a pulse of 154. His training partner says he has been stacking a “fat burner,” testosterone injections, and an online pre-workout powder; the labels are still in his locker. He is hypertensive, agitated, and complaining of chest pressure, but his temperature is rising faster than his friends can cool him. The immediate question is not which supplement he took—it is which complication will declare itself first.
Before You Read
- Which toxidrome guides the first treatment when the product list is unreliable?
- Why are benzodiazepines the central therapy for stimulant toxicity?
- Which performance-enhancing complications require admission even after symptoms improve?
Why It Matters
Performance-enhancement products combine stimulants, anabolic steroids, thyroid agents, diuretics, insulin, erythropoietin, and contaminated supplements. Toxicity may present as a rapidly reversible sympathomimetic emergency—or as myocardial infarction, heat stroke, rhabdomyolysis, hepatic failure, thrombosis, or endocrine collapse.
When to Think of It
Agitation, diaphoresis, mydriasis, tachycardia, hypertension, hyperthermia, chest pain, seizure, or psychosis after “pre-workout,” fat burners, clenbuterol, ephedra-like products, cocaine/amphetamines, thyroid hormone, or injected anabolic agents. Also recognize jaundice, dark urine, severe headache, focal neurologic deficit, unexplained thrombosis, hypoglycemia, or profound electrolyte abnormalities.
Sick or Not Sick
The key call is whether this is a hyperadrenergic emergency with end-organ injury—hyperthermia, ischemia, seizure, dysrhythmia, severe hypertension, acidosis, or rhabdomyolysis—requiring ICU care.
The First Fifteen Minutes
- Agitation, tremor, severe hypertension, tachycardia, or seizure risk: lorazepam 2–4 mg IV, repeated every 5–10 minutes to clinical effect; benzodiazepines reduce central sympathetic outflow and muscle activity. Use airway monitoring.
- Hyperthermia ≥40°C or rapidly rising temperature: active evaporative cooling with mist and fans plus ice packs; cooling stops heat-mediated cellular injury.
- Persistent severe hypertension or ischemic chest pain after sedation: nitroglycerin 5–10 mcg/min IV, titrated; vasodilation reduces coronary demand and blood pressure. Avoid isolated nonselective beta-blockade in suspected stimulant toxicity.
- Hypotension after stimulant toxicity: 0.9% saline 1–2 L IV, then norepinephrine 0.05–0.1 mcg/kg/min IV if shock persists; restore perfusion without worsening adrenergic excess.
- Hypoglycemia, often from insulin or severe exertion: dextrose 25 g IV, with repeat glucose checks; glucose reverses a direct cause of seizures and altered mental status.
- Obtain ECG, glucose, temperature, electrolytes, creatinine, CK, urinalysis, hepatic panel, troponin, VBG/ABG, and pregnancy testing when relevant; urine drug screens rarely identify the actual supplement.
Definitive Care & Disposition
Continue aggressive cooling, IV fluids, serial CK/creatinine/electrolytes, and monitor for rhabdomyolysis, AKI, hyperkalemia, ischemia, dysrhythmia, stroke, and hepatic injury. Treat hyperkalemia according to ECG and laboratory findings; consult toxicology for unknown products. Anabolic-steroid complications may include cholestatic liver injury, thrombosis, cardiomyopathy, mood disorder, and testicular suppression; there is no universal antidote. Erythropoietin increases viscosity and thrombosis risk; growth hormone and thyroid products can cause cardiometabolic toxicity. ICU admission is indicated for hyperthermia, severe agitation, end-organ injury, persistent vital-sign abnormalities, significant rhabdomyolysis, chest pain/troponin elevation, or unreliable follow-up.
How This One Kills
The fatal failure is treating the product label instead of the physiology—allowing stimulant-driven agitation and hyperthermia to continue until rhabdomyolysis, hyperkalemia, coronary ischemia, or intracranial hemorrhage develops.
The Atypical Presentation
Anabolic steroids may present weeks later with jaundice, pruritus, infertility concerns, depression, or cardiomyopathy rather than an acute toxidrome. Erythropoietin toxicity may appear as headache, hypertension, stroke,
pulmonary embolism, or MI. Ask nonjudgmentally about injections, internet products, “research chemicals,” diuretics, insulin, thyroid preparations, and cycling or stacking; patients often disclose the details only after confidentiality is established.
Back to Our Patient
Back to the 22-year-old lifter: diaphoresis, agitation, tachycardia, hypertension, jaw clenching, and rising temperature identify a sympathomimetic toxidrome from an adulterated performance-enhancement stack, regardless of the exact product. He receives IV lorazepam, active cooling, ECG and glucose monitoring, and fluids; persistent chest pressure and hypertension prompt IV nitroglycerin rather than isolated beta-blockade. CK, creatinine, potassium, and troponin rise, confirming end-organ injury, so he is admitted to the ICU for ongoing cooling, serial labs, and monitoring for rhabdomyolysis and myocardial ischemia.
Patient Presentation to Attending
“This is a 22-year-old competitive lifter with acute agitation, diaphoresis, chest pressure, tachycardia, hypertension, and rising hyperthermia after using an unidentified pre-workout product with testosterone and a fat burner. He has mydriasis and jaw clenching without focal neurologic deficit, meningismus, or trauma. His initial ECG shows sinus tachycardia, and CK, creatinine, potassium, and troponin are pending. My leading diagnosis is sympathomimetic toxicity with impending heat injury, while
thyroid storm and serotonin syndrome remain secondary considerations. I’m giving repeated IV lorazepam, initiating active cooling and IV fluids, treating persistent ischemic hypertension with nitroglycerin, and admitting him to the ICU for serial CK, renal, electrolyte, and cardiac monitoring.”
Study Directive
- Create a one-page comparison of stimulant, anabolic-steroid, erythropoietin, growth-hormone, thyroid, and diuretic toxicities.
- Practice the first fifteen minutes of sympathomimetic toxicity from memory, including benzodiazepine and nitroglycerin dosing.
- Review local protocols for hyperthermia, rhabdomyolysis, hyperkalemia, and stimulant-associated chest pain.
- Bring one anonymized supplement label to conference and identify plausible toxic ingredients and missing laboratory complications.